<DOC>
	<DOCNO>NCT02664740</DOCNO>
	<brief_summary>The primary objective study compare efficacy standard treatment associate topical anti-staphylococcal bacteriophage cocktail versus standard treatment plus placebo diabetic foot ulcer monoinfected methicillin-resistant susceptible S. aureus ( MRSA MSSA ) measure relative reduction wind surface area ( % ) 12 week .</brief_summary>
	<brief_title>Standard Treatment Associated With Phage Therapy Versus Placebo Diabetic Foot Ulcers Infected S. Aureus</brief_title>
	<detailed_description>The secondary objective study : A . To compare two study arm term treatment safety tolerance throughout study . B . To compare two study arm term change wound heal week 2 , 4 , 6 , 8 , 10 , 12 . C. To describe change resistance virulence S. aureus ( present wound ) baseline week 4 , modification first-line treatment new antibiotic prescription ( ) week 12 wound still heal . D. To describe two study arm antibiotic resistance status bacteria isolate wound week 4 , modification first-line treatment new antibiotic prescription ( ) week 12 wound still heal . E. To describe two study arm change wind microbiota baseline week 4 , modification first-line treatment new antibiotic prescription ( ) week 12 wound still heal . F. To describe production anti-phage antibody topical treatment : baseline week 4 , modification first-line treatment new antibiotic prescription ( ) , week 12 . G. Creation biobank future ancillary study ( include , limited , cytokine level cellular immune response ) : day 0 week 4 , well week 12 .</detailed_description>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<criteria>Participant preinclusion criterion : The patient must give his/her inform sign consent The patient must insure beneficiary health insurance plan The patient least 18 year old The patient type 1 type 2 diabetes The patient hospitalized/consulting participate centre The patient wound ankle evolve &gt; 2 week The target wound classify P ( 1 2 ) , E ( 130 cm^2 ) , D ( 2 ) , I ( 2 ) S ( 1 2 ) accord PEDIS classification Participant final inclusion criterion : The patient must give his/her inform sign consent The patient must insure beneficiary health insurance plan The patient least 18 year old The patient type 1 type 2 diabetes The patient hospitalized/consulting participate centre The patient wound ankle evolve &gt; 2 week The target wound classify P ( 1 2 ) , E ( 130 cm^2 ) , D ( 2 ) , I ( 2 ) S ( 1 2 ) accord PEDIS classification The patient 's wound monoinfected Staphylococcus aureus ( MRSA MSSA ) Participant preexclusion criterion : The patient participating , participate past three month , another trial The patient participating , participate past three month , another study may interfere result conclusion study The patient exclusion period determine previous study The patient judicial protection , adult guardianship It impossible correctly inform patient The patient refuse sign consent The patient pregnant , parturient breastfeeding Participant final exclusion criterion : The patient participating , participate past three month , another trial The patient participating , participate past three month , another study may interfere result conclusion study The patient exclusion period determine previous study The patient judicial protection , adult guardianship It impossible correctly inform patient The patient refuse sign consent The patient pregnant , parturient breastfeeding Patients receive antibiotic within 7 day precede inclusion Patients diabetic foot wound associated clinical radiographic sign arthritis osteomyelitis* Patients diabetic foot wound associated critical limb ischemia accord P = grade 3 PEDIS classification Patients whose wound infect pathogen S. aureus ( include multiinfections ) accord bacteriological sampling perform preinclusion visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Phage Therapy</keyword>
</DOC>